30 October 2021>: Database Analysis
Construction and Verification of a Hypoxia-Stemness-Based Gene Signature for Risk Stratification in Esophageal Cancer
Kang Tang 1BCDE , Yong Cheng 2AF , Qian Li 3AF*DOI: 10.12659/MSM.934359
Med Sci Monit 2021; 27:e934359
Table 1 Baseline clinicopathological characteristics of patients in the TCGA-ESCA cohort and GSEA53624 cohort.
Characteristics | TCGA-ESCA cohortn (%) | GSEA53624 cohortn (%) |
---|---|---|
Gender | ||
Male | 137 (85%) | 98 (82%) |
Female | 24 (15%) | 21 (18%) |
Age | ||
Mean (SD) | 62.29 (12.05) | 59 (8.89) |
T stage | ||
T1 | 27 (17%) | 8 (7%) |
T2 | 39 (24%) | 20 (17%) |
T3 | 88 (55%) | 62 (52%) |
T4 | 5 (3%) | 29 (24%) |
Tx | 2 (1%) | – |
N stage | ||
N0 | 68 (42%) | 54 (45%) |
N1 | 71 (44%) | 42 (35%) |
N2 | 10 (6%) | 13 (11%) |
N3 | 6 (4%) | 10 (9%) |
Nx | 6 (4%) | – |
M stage | – | |
M0 | 129 (80%) | – |
M1 | 14 (9%) | – |
Mx | 15 (9%) | – |
N/A | 3 (2%) | |
TNM stage | ||
I | 17 (10%) | 6 (5%) |
II | 74 (46%) | 47 (40%) |
III | 56 (35%) | 66 (55%) |
IV | 14 (9%) | – |
SD – standard deviation; Tx – uncertain T stage; Nx – uncertain N stage; Mx – uncertain M stage; N/A – not applicable. |